1-10 of 10
Jenny M. Ho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features and Mutational Landscape of Patients Referred for Suspected Essential Thrombocytosis: A Descriptive Study Using a 'Real-World’ Database

Ala Almanaseer, Benjamin Chin-Yee, Pratibha Bhai, Ian Cheong, Alejandro Lazo-Langner, Jenny M. Ho, Michael A. Levy, Alan Stuart, Hanxin Lin, Ian Chin-Yee, Bekim Sadikovic, Cyrus C. Hsia
Journal: Blood
Blood (2022) 140 (Supplement 1): 7948–7949.
https://doi.org/10.1182/blood-2022-165360
Published: 2022
Journal Articles

Stem Cell-Derived Gene Expression Scores Predict Survival and Leukemic Transformation in Myelofibrosis

Jessie J.F. Medeiros, Andy G.X. Zeng, Michelle Chan-Seng-Yue, Tristan Woo, Jessica L McLeod, Andrea Arruda, Hubert Tsui, Burhan Goraya, Jaime O. Claudio, Jenny M. Ho, James A. Kennedy, Dawn Maze, Hassan Sibai, Mark D. Minden, Jean C.Y. Wang, John E. Dick, Vikas Gupta
Journal: Blood
Blood (2022) 140 (Supplement 1): 9681–9682.
https://doi.org/10.1182/blood-2022-163722
Published: 2022
Journal Articles

Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial

Martha L Louzada, Arleigh McCurdy, Sudeep P Shivakumar, Anthony Quint, Mary Salib, Alejandro Lazo-Langner, Chai Wye Phua, Gregoire Le Gal, Selay Lam, Jenny M. Ho
Journal: Blood
Blood (2021) 138 (Supplement 1): 3232.
https://doi.org/10.1182/blood-2021-148062
Published: 2021
Journal Articles

HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation

Jenny M. Ho, MD, Jessie J.F. Medeiros, BSc, Michelle Chan-Seng-Yue, Lauren Hummel, BSc, Andrea Arruda, Amanda Mitchell, PhD, Caroline J McNamara, MBBS, James A Kennedy, MD PhD, Anne Tierens, MD PhD, Dawn Maze, MDFRCPC,MSc, Hubert Tsui, MD PhD, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, John E. Dick, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1676.
https://doi.org/10.1182/blood-2019-130923
Published: 2019
Journal Articles

Isolation of CD34 − and CD34 + Leukemia Stem Cells from Acute Myeloid Leukemia Blasts Using CD200

Jenny M. Ho, MD, Stephanie M. Dobson, PhD, Jessica McLeod, BSc, Veronique Voisin, PhD, Alex Murison, James Kennedy, MD PhD, Sasan Zandi, MD PhD, Kolja Eppert, MSc, PhD, Mark D. Minden, MD PhD, Mathieu Lupien, John E. Dick, PhD, Jean C.Y. Wang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2790.
https://doi.org/10.1182/blood-2018-99-119318
Published: 2018
Journal Articles

AML-Fated Clones Arise in Stem and Progenitor Cells in Myelofibrosis Patients Several Years Prior to AML Diagnosis

Jenny M. Ho, MD, Jessie James Franco Medeiros, BSc, Michelle Chan-Seng-Yue, Lauren Hummel, BSc, Andrea Arruda, Amanda Mitchell, PhD, Caroline J McNamara, MBBS, James Kennedy, MD PhD, Anne Tierens, MD PhD, Hubert Tsui, MD PhD, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, John E. Dick, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4321.
https://doi.org/10.1182/blood-2018-99-118889
Published: 2018
Journal Articles

Myelofibrosis Is Initiated and Sustained By Rare Multipotent Stem Cells

Jessie J.F. Medeiros, BSc, Amanda Mitchell, PhD, Aaron Trotman-Grant, Tristan Woo, Jenny M. Ho, MD, Andrea Arruda, Mark D. Minden, MD PhD, John E. Dick, PhD, Vikas Gupta, MD FRCP, FRCPath, Liran I. Shlush, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1790.
https://doi.org/10.1182/blood-2018-99-119088
Published: 2018
Journal Articles

CD200 Is a Marker of LSC Activity in Acute Myeloid Leukemia

Jenny M. Ho, MD, Stephanie M. Dobson, Jessica McLeod, Liqing Jin, MD PhD, Stanley W.K. Ng, MSc, Amanda Mitchell, PhD, Liran I. Shlush, MD PhD, Sasan Zandi, MD PhD, Kolja Eppert, PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Jean C.Y. Wang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1705.
https://doi.org/10.1182/blood.V128.22.1705.1705
Published: 2016
Journal Articles

Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy

Jay Spiegel, MD, Caroline Jane McNamara, MBBS, Andrea Arruda, MSc., Tony Panzarella, BSc MSc, James A. Kennedy, MD PhD, Tracy L. Stockley, PhD, Mahadeo Sukhai, BSc, MSc, PhD, Mariam Thomas, PhD, Justyna Bartoszko, MD, Jenny M. Ho, MD, Nancy Siddiq, RN, BScN, Aaron D. Schimmer, MD PhD, Andre C. Schuh, MD FRCPC, Hassan Sibai, MD, Karen W.L. Yee, MD, Jaime O. Claudio, PhD, Rebecca Devlin, PhD, Mark D. Minden, MD PhD, Suzanne Kamel-Reid, PhD DABMG, FACMG, Vikas Gupta, MD FRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 4263.
https://doi.org/10.1182/blood.V128.22.4263.4263
Published: 2016
Journal Articles

Functional and Phenotypic Characterization Of Acute Myeloid Leukemia By Analysis Of Diagnostic/Relapse Paired Samples

Jenny M. Ho, MD, Liran I. Shlush, MD, PhD, Amanda Mitchell, PhD, Rene Marke, Jessica McLeod, Mark D. Minden, MD PhD, John E. Dick, PhD, Jean C.Y. Wang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2595.
https://doi.org/10.1182/blood.V122.21.2595.2595
Published: 2013